Eva Segelov Selected Research

Eva Segelov Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 01/2014
26	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2004
7	COVID-19 01/2024 - 10/2021
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2017
3	Disease Progression 10/2023 - 01/2014
3	Multiple Sclerosis 02/2023 - 05/2022
3	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 01/2021
3	Infections 05/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 12/2019 - 07/2005
3	Fatigue 12/2019 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 11/2023
2	Hypertension (High Blood Pressure) 11/2023 - 11/2016
2	Chronic Disease (Chronic Diseases) 01/2023 - 12/2019
2	Hypersensitivity (Allergy) 01/2022 - 06/2021
2	Anus Neoplasms (Anal Cancer) 12/2021 - 01/2020
2	Cardiotoxicity 04/2021 - 03/2012
2	Stomach Neoplasms (Stomach Cancer) 02/2019 - 04/2012
1	Myocardial Infarction 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 12/2022
1	Thrombosis (Thrombus) 12/2022
1	Body Weight (Weight, Body) 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 12/2021
1	Hypopituitarism (Sheehan's Syndrome) 12/2021
1	Metrorrhagia (Spotting) 10/2021
1	Lower Urinary Tract Symptoms 10/2021
1	Pain (Aches) 10/2021
1	Adenocarcinoma 09/2021
1	Protein Deficiency 07/2021
1	Microsatellite Instability 03/2021
1	Dihydropyrimidine Dehydrogenase Deficiency 01/2021
1	Rectal Neoplasms (Rectal Cancer) 01/2021
1	Turcot syndrome 03/2018
1	Smallpox (Variola) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2017
1	Cholelithiasis 09/2017
1	Exanthema (Rash) 01/2017
1	Stomatitis 01/2017

Drug/Important Bio-Agent (IBA)

10	VaccinesIBA 01/2024 - 01/2018
9	COVID-19 VaccinesIBA 01/2024 - 01/2022
6	Immune Checkpoint InhibitorsIBA 12/2023 - 03/2021
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 01/2016
4	AntibodiesIBA 08/2021 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 04/2021 - 02/2019
4	Bevacizumab (Avastin)FDA Link 01/2020 - 12/2014
4	Cetuximab (Erbitux)FDA Link 12/2018 - 12/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2020
3	Fluorouracil (Carac)FDA LinkGeneric 08/2021 - 01/2020
3	Irinotecan (Camptosar)FDA LinkGeneric 12/2018 - 01/2016
3	ErbB Receptors (EGF Receptor)IBA 10/2018 - 01/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2014
2	Panitumumab (Vectibix)FDA Link 08/2021 - 12/2014
2	Trastuzumab (Herceptin)FDA Link 02/2019 - 03/2012
2	Everolimus FDA Link 01/2017 - 01/2017
2	Capecitabine (Xeloda)FDA Link 11/2016 - 01/2014
2	Monoclonal AntibodiesIBA 01/2016 - 01/2016
1	AntigensIBA 10/2022
1	Polysorbates (PSML)FDA Link 01/2022
1	Dosage Forms (Dosage Form)IBA 01/2022
1	methanesulfonic acid (methanesulfonate)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Chromogranin AIBA 01/2022
1	Testosterone (Sustanon)FDA Link 12/2021
1	Radioisotopes (Radionuclides)IBA 12/2021
1	Growth Hormone (Somatotropin)IBA 12/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021
1	salicylhydroxamic acid (SHAM)IBA 10/2021
1	A-Form DNA (A-DNA)IBA 07/2021
1	AntiemeticsIBA 04/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2021
1	Hormones (Hormone)IBA 04/2021
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 04/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2017
1	lanreotide (Somatuline)FDA Link 01/2017

Therapy/Procedure

33	Therapeutics 04/2024 - 07/2005
22	Drug Therapy (Chemotherapy) 01/2022 - 01/2010
7	Adjuvant Chemotherapy 01/2021 - 08/2014
3	Immunotherapy 04/2021 - 01/2020
2	Castration 04/2021 - 01/2021
2	Neoadjuvant Therapy 01/2021 - 01/2021
2	Aftercare (After-Treatment) 01/2017 - 11/2012
2	Secondary Prevention 01/2014 - 11/2012
1	Continuity of Patient Care 01/2023
1	Lasers (Laser) 10/2021
1	Precision Medicine 09/2021
1	Chemoradiotherapy 01/2020
1	Radiotherapy 01/2020
1	Resistance Training 12/2019
1	Combination Drug Therapy (Combination Chemotherapy) 11/2018
1	Duration of Therapy 01/2018
1	Palliative Care (Palliative Therapy) 10/2017
1	Exercise Therapy (Therapy, Exercise) 01/2017